Kassianides, Xenophon
Bhandari, Sunil
Article History
Received: 21 July 2023
Accepted: 14 December 2023
First Online: 12 February 2024
Declarations
:
: The “Iron and Phosphaturia – ExplorIRON-CKD” (EudraCT number: 2019–004370-26 / ExternalRef removed / First date of trial registration: 03/12/2019) was performed in accordance with Good Clinical Practice guidelines, the Declaration of Helsinki. The trial received the favorable opinion of the Health Research Authority and the Research Ethics Committee Leeds West (20/YH/0005), and clinical trial authorization by the Medicines and Healthcare Products Regulatory Agency of the United Kingdom. Study participants had all details explained to them in writing and in person before giving informed consent.
: Not applicable.
: XK has no conflicts of interest. SB has received honorarium for lectures, attended expert opinion committees and received educational funds to attend international Nephrology meetings from Pharmacosmos A/S and Vifor Pharma.